NICE: Its influence in treating osteoporosis in the UK and beyond

Therapeutic Advances in Musculoskeletal Disease

Volumn 1, Issue 2, 2009, Pages 63-66

  Compston, Juliet ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84993728977     PISSN: 1759720X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1759720X09354945     Document Type: Editorial

References (19)

1. Compston, J. (in press) Recent advances in the management of osteoporosis. J R Coll Physicians.
2. Compston, J., Cooper, A., Cooper, C., Francis, R., Kanis, J.A., Marsh, D. et al. (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas 62: 105-108.
3. Dawson-Hughes, B., Tosteson, A.N., Melton 3rd, L.J., Baim, S., Favus, M.J., Khosla, S. et al. (2008) National Osteoporosis Foundation Guide Committee (2008) Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int 19: 449-458.
4. Delmas, P.D. and Siris, E.S. ( 2008) NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women. Bone 42: 16-18.
5. Dolan, P. and Torgerson, D.J. ( 2000) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 11: 551-552.
6. Kanis, J.A. on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary health-care level. Technical Report. WHO Collaborating Centre, University of Sheffield, UK.
7. Kanis, J.A. and Compston, J.E. ( 2008) NICE continues to muddy the waters of osteoporosis. Osteoporos Int 19: 1105-1107.
8. Kanis, J.A., Johansson, H., Oden, A., Johnell, O., de Laet, C., Melton, L.J. et al. (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19: 893-899.
9. Kanis, J.A., Johansson, H., Johnell, O., Oden, A., de Laet, C., Eisman, J. et al. (2005 a) Alcohol intake as a risk factor for fracture. Osteoporos Int 16: 737-742.
10. Kanis, J.A., Johnell, O., Oden, A., Johansson, H., de Laet, C., Eisman, J. et al. (2005 b) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16: 222-228.
11. Kanis, J.A., Johnell, O., Oden, A., Johansson, H. and McCloskey, E. ( 2008a) FRAXTM and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19: 385-397.
12. Kanis, J.A., Adams, J., Borgström, F., Cooper, C., Jönsson, B., Preedy, D. et al. (2008 b) The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42: 4-15.
13. Kanis, J.A., McCloskey, E.V., Johansson, H., Strom, O., Borgstrom, F. and Oden, A. and the National Osteoporosis Guideline Group. ( 2008c) Case finding for the management of osteoporosis with FRAXTM - assessment and intervention thresholds for the UK. Osteoporos Int 19: 1395-1408.
14. Kanis, J.A., Burlet, N., Cooper, C., Delmas, P.D., Reginster, J.Y., Borgström, F. et al. on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). ( 2008d) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19: 399-428.
15. National Institute for Health and Clinical Excellence. Final appraisal determination. (2005) Alendronate, etidronate, risedronate and raloxifene for the secondary prevention of osteoporotic fragility fractures in postmenopausal women, NICE: London.
16. National Institute for Health and Clinical Excellence. ( 2008a) Final appraisal determination. Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (2008), NICE: London.
17. National Institute for Health and Clinical Excellence. ( 2008b) Final appraisal determination. Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women, NICE: London.
18. Poole, K.E. and Compston, J.E. ( 2006) Osteoporosis and its management. Brit Med J 333: 1251-1256.
19. The Independent, 11 March 1995, UK.